Hematological Malignancies

Showing NaN - NaN of 11

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hematological Malignancies Trial in Worldwide (Pembrolizumab/vibostolimab coformuation)

Recruiting
  • Hematological Malignancies
  • Pembrolizumab/vibostolimab coformuation
  • Duarte, California
  • +64 more
Jan 27, 2023

Hematological Malignancies Trial in United Kingdom, United States (Magrolimab, Azacitidine)

Active, not recruiting
  • Hematological Malignancies
  • Duarte, California
  • +26 more
Dec 7, 2022

Hematological Malignancies Trial in Worldwide (Talquetamab)

Recruiting
  • Hematological Malignancies
  • Birmingham, Alabama
  • +82 more
Aug 11, 2022

Hematological Malignancies, Multiple Myeloma, Hodgkin's Lymphoma Trial in Worldwide (Tinostamustine)

Recruiting
  • Hematological Malignancies
  • +3 more
  • Phoenix, Arizona
  • +19 more
Apr 12, 2022

Hematological Malignancies Trial in Georgia, Poland, United States (Tenalisib)

Enrolling by invitation
  • Hematological Malignancies
  • San Francisco, California
  • +6 more
Nov 1, 2021

Hematological Malignancies Trial in Canada, Denmark, United States (KPT-330)

Completed
  • Hematological Malignancies
  • Tampa, Florida
  • +11 more
Mar 5, 2021

Hematological Malignancies, Myelodysplastic Syndrome, Leukemia Trial in Houston (Mycophenolate Mofetil (MMF), Thymoglobulin,

Terminated
  • Hematological Malignancies
  • +3 more
  • Mycophenolate Mofetil (MMF)
  • +3 more
  • Houston, Texas
    UT MD Anderson Cancer Center
Sep 1, 2020

Hematological Malignancies Trial in Houston (ABT-751)

Completed
  • Hematological Malignancies
  • Houston, Texas
    The University of Texas M.D. Anderson Cancer Center
Oct 30, 2018

Hematological Malignancies Trial in Houston (Ibandronate, Vitamin Supplements)

Completed
  • Hematological Malignancies
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 12, 2018

Hematological Malignancies Trial in Washington, Houston, Toronto (Obatoclax mesylate (GX15-070MS))

Completed
  • Hematological Malignancies
  • Obatoclax mesylate (GX15-070MS)
  • Washington, District of Columbia
  • +2 more
May 9, 2014

Hematological Malignancies Trial in Houston (Ribavirin)

Completed
  • Hematological Malignancies
  • Houston, Texas
    U.T.M.D. Anderson Cancer Center
Jul 27, 2012